Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antipsychotic Agents | 10 | 2021 | 247 | 3.530 |
Why?
|
| Schizophrenia | 6 | 2021 | 206 | 1.590 |
Why?
|
| Receptors, Dopamine D2 | 7 | 2021 | 109 | 1.450 |
Why?
|
| Haloperidol | 5 | 2020 | 95 | 1.360 |
Why?
|
| Dopamine | 6 | 2018 | 474 | 1.090 |
Why?
|
| Behavior | 2 | 2017 | 59 | 1.040 |
Why?
|
| Serotonin | 4 | 2015 | 144 | 0.880 |
Why?
|
| Cultural Evolution | 1 | 2022 | 2 | 0.850 |
Why?
|
| Drinking | 2 | 2012 | 35 | 0.720 |
Why?
|
| Rats, Transgenic | 3 | 2016 | 24 | 0.620 |
Why?
|
| Quinpirole | 3 | 2015 | 26 | 0.620 |
Why?
|
| Motor Activity | 3 | 2016 | 621 | 0.570 |
Why?
|
| Caudate Nucleus | 3 | 2012 | 56 | 0.570 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2016 | 2 | 0.570 |
Why?
|
| Mental Disorders | 1 | 2022 | 659 | 0.570 |
Why?
|
| Neurotransmitter Agents | 2 | 2014 | 102 | 0.560 |
Why?
|
| Nucleus Accumbens | 4 | 2021 | 417 | 0.560 |
Why?
|
| Cocaine | 1 | 2021 | 555 | 0.540 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2015 | 20 | 0.500 |
Why?
|
| Serotonin Antagonists | 1 | 2015 | 31 | 0.500 |
Why?
|
| Dopamine Agents | 1 | 2015 | 56 | 0.490 |
Why?
|
| Rats | 11 | 2021 | 5300 | 0.470 |
Why?
|
| Putamen | 2 | 2011 | 35 | 0.470 |
Why?
|
| Light | 1 | 2015 | 152 | 0.470 |
Why?
|
| Judgment | 1 | 2014 | 40 | 0.460 |
Why?
|
| Goals | 1 | 2014 | 65 | 0.450 |
Why?
|
| Animals | 21 | 2021 | 20881 | 0.430 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2021 | 2083 | 0.430 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2012 | 12 | 0.420 |
Why?
|
| Behavior, Animal | 2 | 2014 | 470 | 0.410 |
Why?
|
| Dopamine Agonists | 1 | 2012 | 68 | 0.400 |
Why?
|
| Physical Stimulation | 1 | 2011 | 67 | 0.370 |
Why?
|
| Norepinephrine | 1 | 2011 | 276 | 0.360 |
Why?
|
| Motivation | 1 | 2014 | 561 | 0.350 |
Why?
|
| Brain | 3 | 2021 | 2176 | 0.340 |
Why?
|
| Prefrontal Cortex | 2 | 2011 | 640 | 0.320 |
Why?
|
| Synaptic Vesicles | 2 | 2020 | 18 | 0.290 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2550 | 0.250 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 28 | 0.240 |
Why?
|
| Secologanin Tryptamine Alkaloids | 2 | 2014 | 4 | 0.230 |
Why?
|
| Antidepressive Agents | 2 | 2016 | 216 | 0.230 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2016 | 183 | 0.220 |
Why?
|
| Synaptic Transmission | 2 | 2016 | 236 | 0.220 |
Why?
|
| Knowledge | 1 | 2022 | 18 | 0.210 |
Why?
|
| Microdialysis | 3 | 2012 | 147 | 0.210 |
Why?
|
| Exploratory Behavior | 3 | 2015 | 79 | 0.210 |
Why?
|
| Basal Forebrain | 1 | 2021 | 15 | 0.190 |
Why?
|
| Appetitive Behavior | 2 | 2011 | 18 | 0.190 |
Why?
|
| Heroin | 1 | 2021 | 49 | 0.190 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2011 | 26 | 0.190 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 87 | 0.190 |
Why?
|
| Presynaptic Terminals | 1 | 2020 | 34 | 0.190 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
| Piperazines | 2 | 2015 | 206 | 0.180 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.180 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2018 | 82 | 0.180 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 191 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1745 | 0.170 |
Why?
|
| Drug Administration Schedule | 2 | 2011 | 567 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 157 | 0.170 |
Why?
|
| Hippocampus | 3 | 2020 | 471 | 0.160 |
Why?
|
| Neurons | 3 | 2015 | 881 | 0.160 |
Why?
|
| Humans | 13 | 2022 | 68618 | 0.150 |
Why?
|
| Ethanol | 2 | 2016 | 893 | 0.150 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.150 |
Why?
|
| Male | 10 | 2021 | 37321 | 0.150 |
Why?
|
| Dopamine D2 Receptor Antagonists | 2 | 2020 | 13 | 0.150 |
Why?
|
| Sensory Gating | 1 | 2016 | 4 | 0.140 |
Why?
|
| Prodromal Symptoms | 1 | 2016 | 5 | 0.140 |
Why?
|
| Rats, Wistar | 2 | 2015 | 371 | 0.140 |
Why?
|
| Autopsy | 1 | 2016 | 56 | 0.140 |
Why?
|
| Reflex, Startle | 1 | 2016 | 39 | 0.140 |
Why?
|
| Amphetamine | 1 | 2016 | 77 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2015 | 32 | 0.130 |
Why?
|
| Ritanserin | 1 | 2015 | 5 | 0.130 |
Why?
|
| Phencyclidine | 1 | 2015 | 17 | 0.130 |
Why?
|
| Parkinsonian Disorders | 1 | 2015 | 43 | 0.130 |
Why?
|
| Homeostasis | 1 | 2016 | 291 | 0.130 |
Why?
|
| Naphthyridines | 1 | 2015 | 20 | 0.130 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.120 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.120 |
Why?
|
| Piperidines | 1 | 2015 | 123 | 0.120 |
Why?
|
| Photic Stimulation | 1 | 2015 | 229 | 0.120 |
Why?
|
| Receptors, Serotonin | 1 | 2014 | 74 | 0.120 |
Why?
|
| Ketamine | 1 | 2015 | 57 | 0.120 |
Why?
|
| Indoles | 1 | 2015 | 146 | 0.120 |
Why?
|
| Synapses | 2 | 2015 | 222 | 0.110 |
Why?
|
| Sphingolipids | 1 | 2016 | 337 | 0.110 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2013 | 8 | 0.110 |
Why?
|
| Pyridines | 1 | 2015 | 261 | 0.110 |
Why?
|
| Mitragyna | 1 | 2012 | 7 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 266 | 0.110 |
Why?
|
| Dopaminergic Neurons | 1 | 2013 | 46 | 0.100 |
Why?
|
| Polydipsia, Psychogenic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 12 | 0.100 |
Why?
|
| Microinjections | 1 | 2012 | 130 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2012 | 107 | 0.100 |
Why?
|
| Analgesics | 1 | 2012 | 118 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2011 | 86 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2011 | 173 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 189 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2012 | 156 | 0.090 |
Why?
|
| Pain Threshold | 1 | 2011 | 55 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1664 | 0.090 |
Why?
|
| Learning | 1 | 2012 | 186 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2012 | 279 | 0.090 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2013 | 272 | 0.090 |
Why?
|
| Depression | 1 | 2016 | 943 | 0.090 |
Why?
|
| Ceramides | 1 | 2013 | 578 | 0.080 |
Why?
|
| Mice | 6 | 2021 | 8474 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 317 | 0.080 |
Why?
|
| Clomipramine | 1 | 2008 | 8 | 0.080 |
Why?
|
| Thiazepines | 1 | 2008 | 14 | 0.080 |
Why?
|
| Clozapine | 1 | 2008 | 46 | 0.080 |
Why?
|
| Pyrroles | 1 | 2008 | 83 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2008 | 130 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2008 | 411 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2014 | 1242 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2673 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 805 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7029 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2015 | 351 | 0.060 |
Why?
|
| Conditioning, Operant | 2 | 2016 | 241 | 0.050 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.050 |
Why?
|
| DNA, Ribosomal | 1 | 2021 | 59 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| Sucrose | 1 | 2021 | 58 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 150 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2020 | 25 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
| Self Administration | 1 | 2021 | 419 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2021 | 240 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 208 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 244 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 270 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 682 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 236 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 2791 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
| Reflex, Righting | 1 | 2016 | 4 | 0.040 |
Why?
|
| Food Preferences | 1 | 2016 | 46 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2016 | 85 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 149 | 0.030 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2015 | 2 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2015 | 37 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 2689 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 248 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 282 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 114 | 0.030 |
Why?
|
| Delta Rhythm | 1 | 2014 | 11 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2015 | 106 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 2014 | 6 | 0.030 |
Why?
|
| Memory Consolidation | 1 | 2014 | 7 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 25 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2014 | 58 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 1033 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 2014 | 107 | 0.030 |
Why?
|
| Locomotion | 1 | 2014 | 135 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2015 | 224 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 954 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 63 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 38 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 2012 | 5 | 0.030 |
Why?
|
| Self Medication | 1 | 2012 | 25 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 176 | 0.030 |
Why?
|
| Alkaloids | 1 | 2012 | 40 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2012 | 26 | 0.030 |
Why?
|
| Mifepristone | 1 | 2012 | 7 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2012 | 20 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 23 | 0.030 |
Why?
|
| Biophysics | 1 | 2012 | 41 | 0.030 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 40 | 0.030 |
Why?
|
| Exocytosis | 1 | 2012 | 34 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2012 | 120 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2012 | 200 | 0.030 |
Why?
|
| Endocytosis | 1 | 2012 | 113 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 204 | 0.020 |
Why?
|
| Consciousness | 1 | 2011 | 17 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2012 | 122 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 289 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 397 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 218 | 0.020 |
Why?
|
| Amines | 1 | 2012 | 98 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2012 | 136 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 396 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2012 | 109 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 765 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 618 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 782 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1038 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 439 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 706 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1027 | 0.020 |
Why?
|